Condition / Treatment metabolic

Vitamin B12 deficiency and Metformin

Metformin is a first-line medication for type 2 diabetes and is also used off-label for polycystic ovary syndrome (PCOS). A well-documented, though often under-recognized, effect of long-term metformin therapy is reduced vitamin B12 status. Understanding how and why this happens helps patients and clinicians prevent avoidable complications like neuropathy and anemia. Metformin appears to interfere with vitamin B12 absorption mainly in the last segment of the small intestine, where B12 bound to intrinsic factor is normally taken up via a calcium-dependent mechanism. Research suggests metformin alters this calcium-mediated transport, and may also change gut motility and bile salt metabolism, contributing to malabsorption. The effect is dose- and duration-related: higher daily doses and use over several years increase risk. Randomized and long-term cohort studies show lower serum B12 and higher functional deficiency markers (methylmalonic acid and homocysteine) in metformin users compared with non-users. How common is this? Estimates vary by population and criteria, but clinically low or borderline B12 levels are found in a meaningful minority of metformin users. Risk is higher in people who have been on metformin for years, take higher doses, are older, eat little or no animal products, use acid-suppressing medicines (PPIs/H2 blockers), or have had bariatric surgery. B12 stores can last years, so deficiencies may not appear until 2–5 years after initiation, though drops in levels can emerge within the first year. Clinical consequences overlap with conditions already common in diabetes: peripheral neuropathy (numbness, tingling, burning), gait instability, cognitive changes, glossitis, and macrocytic anemia. Because diabetic neuropathy and B12-related neuropathy look similar, deficiency can be missed unless specifically tested. A typical laboratory workup includes a complete blood count (looking for macrocytosis), serum B12 (low or borderline values), and—when the B

Updated March 25, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Shared Risk Factors

Higher metformin daily dose

Moderate Evidence

Risk of B12 lowering rises with increasing metformin dose; studies show greater odds of deficiency at higher doses.

Greater likelihood of biochemical and functional B12 deficiency.
Dose escalation strengthens glycemic effect but increases B12 malabsorption risk.

Longer duration of metformin therapy

Strong Evidence

Cumulative exposure over years depletes body B12 stores; long-term trials show progressive declines.

Higher chance of symptomatic deficiency (neuropathy, anemia) over time.
Sustained use preserves glycemic benefits but increases deficiency risk.

Older age

Moderate Evidence

Aging reduces gastric acid and intrinsic factor in some individuals, compounding metformin-related malabsorption.

Greater baseline vulnerability to low B12 and neurologic sequelae.
Older adults are more likely to be long-term metformin users.

Concomitant acid suppression (PPIs/H2 blockers)

Strong Evidence

These medicines reduce gastric acid needed to liberate B12 from food; combined with metformin, risk increases.

Higher odds of low or borderline B12.
Common co-prescription in diabetes due to GERD prevalence.

Low dietary B12 intake (vegetarian/vegan)

Moderate Evidence

Low intake reduces B12 reserves that buffer against metformin-related malabsorption.

Faster progression from subclinical to clinical deficiency.
No direct effect on metformin efficacy, but increases deficiency risk while on therapy.

History of bariatric surgery or malabsorptive GI disease

Moderate Evidence

Reduced intrinsic factor production or ileal surface area impairs B12 uptake; metformin adds further impairment.

High risk of persistent deficiency without supplementation.
Metformin use remains beneficial for glycemia but requires closer B12 surveillance.

Overlapping Treatments

Vitamin B12 supplementation (oral or intramuscular)

Strong Evidence
Benefits for Vitamin B12 deficiency

Corrects biochemical deficiency and improves hematologic and neurologic outcomes.

Benefits for Metformin

Allows continuation of metformin while mitigating deficiency-related adverse effects.

Formulation and route tailored to severity and malabsorption; monitor response with labs and symptoms.

Periodic B12 monitoring protocol

Strong Evidence
Benefits for Vitamin B12 deficiency

Early detection of low or borderline B12 prevents progression to symptomatic deficiency.

Benefits for Metformin

Supports safe long-term metformin use with timely intervention.

Frequency individualized; prioritize those with neuropathy, anemia, or multiple risk factors.

Dietary B12 from animal foods or fortified foods

Moderate Evidence
Benefits for Vitamin B12 deficiency

Maintains or improves B12 status, especially in low-intake patterns.

Benefits for Metformin

Non-pharmacologic support enabling ongoing metformin therapy.

May be insufficient alone in significant malabsorption or post-bariatric states.

Review/optimization of acid-suppressing therapy

Moderate Evidence
Benefits for Vitamin B12 deficiency

Reducing unnecessary PPI/H2 blocker use may improve B12 absorption.

Benefits for Metformin

Minimizes compounding factors that increase deficiency risk during metformin therapy.

Changes should follow clinical guidelines; balance GERD control and nutrient risks.

Calcium supplementation (to counter metformin-related malabsorption)

Emerging Research
Benefits for Vitamin B12 deficiency

Small studies suggest improved ileal B12 uptake in metformin users.

Benefits for Metformin

May mitigate a mechanism of metformin-induced B12 malabsorption without altering glycemic effect.

Evidence is limited; consider individual cardiovascular and renal risk before adding calcium.

Medical Perspectives

Western Perspective

Western medicine recognizes vitamin B12 deficiency as a common, dose- and duration-related adverse effect of metformin. Mechanistically, metformin impairs calcium-dependent uptake of the intrinsic factor–B12 complex in the terminal ileum and may alter gut motility and microbiota, resulting in malabsorption. Major guidelines advise periodic assessment of B12, especially in long-term users and those with neuropathy or anemia.

Key Insights

  • Long-term randomized and cohort studies show lower B12 and higher methylmalonic acid/homocysteine with metformin compared to controls.
  • Risk rises with higher daily dose and longer exposure; older adults and those on PPIs/H2 blockers are particularly vulnerable.
  • B12 deficiency can mimic or worsen diabetic peripheral neuropathy, so targeted testing is essential to avoid misattribution.
  • Screening with serum B12 plus confirmatory functional markers (MMA, homocysteine) allows early detection and treatment.
  • High-dose oral B12 is often as effective as intramuscular therapy for many patients; route depends on severity and absorption.

Treatments

  • Periodic B12 screening (serum B12 with reflex MMA/homocysteine when borderline)
  • B12 repletion (oral or intramuscular), with follow-up labs and symptom assessment
  • Address modifiable risks (optimize acid suppression, nutrition counseling)
  • Consider calcium to counter absorption mechanism (limited evidence)
  • Neurology/hematology referral for severe or atypical presentations
Evidence: Strong Evidence

Sources

  • American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care.
  • MHRA Drug Safety Update (UK), 2022: Metformin and reduced vitamin B12 levels.
  • de Jager J et al. BMJ 2010; Long-term metformin RCT showing B12 lowering.
  • Aroda VR et al. Diabetes Care 2016; DPPOS: B12 deficiency, anemia, neuropathy associations.
  • Cochrane Review 2018: Oral vs intramuscular vitamin B12 for deficiency.

Eastern Perspective

Traditional systems frame fatigue, numbness, and cognitive fog as disruptions in vital energy, blood, and digestion. While vitamin B12 as a molecule is a modern construct, many Eastern approaches aim to strengthen digestive assimilation and nourish the nervous system—complementary goals when addressing B12 deficiency during metformin therapy. Integrative clinicians often combine conventional B12 testing and repletion with acupuncture or herbal strategies focused on digestive resilience and neuropathic symptom relief.

Key Insights

  • In Traditional Chinese Medicine (TCM), patterns like Spleen Qi deficiency and Kidney Essence depletion can map to fatigue, paresthesias, and anemia-like presentations; therapy emphasizes enhancing digestion and nourishing Blood.
  • Ayurveda’s concept of impaired agni (digestive fire) and rasadhatu depletion parallels poor nutrient assimilation; Rasayana strategies and diet tailored to constitution may support overall vitality.
  • Acupuncture has emerging evidence for improving symptoms of diabetic neuropathy, potentially complementing B12 repletion.
  • Dietary guidance emphasizing easily assimilated, nutrient-dense foods and mindful eating aligns with goals to improve B12 status, especially for low-animal-product diets.
  • Eastern therapies are viewed as adjuncts; they do not replace laboratory assessment and B12 repletion when deficiency is present.

Treatments

  • Acupuncture for neuropathy symptoms and circulation support
  • TCM herbal formulas individualized to support digestion and Blood (e.g., Si Jun Zi Tang variants)
  • Ayurvedic Rasayana and digestive tonics under practitioner guidance
  • Mindful, constitution-appropriate diet with emphasis on nutrient density and, when appropriate, fortified foods
Evidence: Emerging Research

Sources

  • WHO and systematic reviews on acupuncture for diabetic neuropathy (mixed but promising evidence).
  • TCM and Ayurveda classical texts on digestive strengthening and neuropathy analogues (traditional sources).
  • Integrative reviews discussing B12 deficiency within holistic care frameworks.

Evidence Ratings

Long-term metformin therapy lowers serum B12 and raises MMA/homocysteine compared with placebo.

de Jager J et al. BMJ 2010; randomized controlled trial.

Strong Evidence

Risk of B12 deficiency with metformin increases with higher dose and longer duration of use.

Aroda VR et al. Diabetes Care 2016; DPPOS observational analyses.

Moderate Evidence

Major guidelines recommend periodic assessment of B12 in long-term metformin users, especially with anemia or neuropathy.

ADA Standards of Care 2024; MHRA Drug Safety Update 2022.

Strong Evidence

B12 deficiency can mimic or exacerbate diabetic peripheral neuropathy.

DPPOS (Diabetes Care 2016) association of low B12 with neuropathy signs.

Moderate Evidence

High-dose oral B12 can be as effective as intramuscular B12 for correcting deficiency in many patients.

Cochrane Review 2018: Oral vs intramuscular vitamin B12.

Strong Evidence

Concomitant PPI/H2 blocker use is associated with higher odds of vitamin B12 deficiency.

Lam JR et al. JAMA 2013; case-control study in large health system.

Strong Evidence

Calcium supplementation may reverse metformin-induced B12 malabsorption by restoring ileal uptake.

Bauman WA et al. Diabetes Care 2000; small interventional study.

Emerging Research

Western Medicine Perspective

From a Western clinical standpoint, the relationship between metformin and vitamin B12 deficiency is one of predictable physiology and measurable outcomes. Metformin remains indispensable for type 2 diabetes and is widely used in PCOS because it improves insulin sensitivity, lowers hepatic glucose production, and reduces cardiovascular risk markers. Yet, multiple lines of evidence show that metformin, through its actions in the small intestine, impairs the calcium-dependent uptake of the intrinsic factor–B12 complex at the terminal ileum. Randomized data demonstrate that, over years, metformin users have significantly lower B12 levels and higher methylmalonic acid and homocysteine—biomarkers of functional deficiency—than matched controls. The effect scales with dose and duration; older adults and those on acid-suppressing therapy are particularly susceptible. Clinically, this matters because B12 deficiency can present with macrocytic anemia, glossitis, and neurocognitive changes, but most relevant to diabetes care, it can mimic or worsen distal symmetric polyneuropathy. Without targeted testing, clinicians may attribute numbness and burning pain entirely to diabetes and escalate neuropathy medications while missing a reversible contributor. A pragmatic laboratory pathway begins with a complete blood count and serum B12; borderline results should reflex to methylmalonic acid and/or homocysteine to confirm functional deficiency. Holotranscobalamin can be useful where available. Management is straightforward: continue metformin’s metabolic benefits while correcting B12 status with supplementation (oral or intramuscular, chosen by severity, absorption, and patient preference), and address compounding factors such as unnecessary PPI/H2 blocker use and low dietary intake. Monitoring for biochemical response and symptom improvement closes the loop. Guidelines from the ADA and regulators such as the UK MHRA advise periodic B12 assessment in long-term metformin users, especially when anemia or neuropathy is present, underscoring that deficiency is both foreseeable and preventable. In short, the evidence supports a proactive strategy: identify those at higher risk, screen at sensible intervals, treat confirmed or likely deficiency, and preserve the proven benefits of metformin while minimizing avoidable neurologic and hematologic harms.

Eastern Medicine Perspective

Traditional and integrative perspectives view the metformin–B12 connection through the lens of nourishment, digestion, and neural vitality. In Traditional Chinese Medicine, fatigue, numbness, and mental fog often reflect Spleen Qi deficiency and Blood insufficiency, with Kidney Essence depletion contributing to chronic neuropathic patterns. Metformin’s gastrointestinal effects—altered motility and assimilation—map to impaired transformation and transportation functions of the Spleen. TCM treatment might combine acupuncture to improve peripheral circulation and reduce paresthesia with herbal formulas tailored to fortify digestion and nourish Blood. Evidence for acupuncture in diabetic neuropathy is emerging, with some trials reporting symptomatic relief—an adjunct to, not a replacement for, B12 repletion when deficiency is documented. Ayurveda frames similar complaints as manifestations of manda agni (low digestive fire) and vata aggravation affecting the majja dhatu (nervous tissue). Strategies include Rasayana approaches to restore resilience, gentle digestive tonics, and diet suited to the individual constitution, emphasizing warm, easy-to-digest, nutrient-dense foods. For those avoiding animal products, integrative practitioners encourage conscious inclusion of fortified foods and mindful eating practices to support assimilation. Naturopathic care may layer in lifestyle measures for glycemic balance while prioritizing laboratory assessment and targeted B12 repletion to address the root biochemical gap. Across Eastern traditions, a unifying theme is partnership with conventional care: laboratory testing guides interventions; B12 supplementation corrects deficiency; and acupuncture, diet, and herbal support help manage neuropathic symptoms and digestive side effects of metformin. This complementary approach respects both biochemical specificity and whole-person healing—aiming to preserve metformin’s metabolic advantages while strengthening the body’s capacity to absorb, nourish, and repair.

Sources
  1. American Diabetes Association. Standards of Care in Diabetes—2024. Diabetes Care.
  2. Medicines and Healthcare products Regulatory Agency (MHRA). Drug Safety Update, Nov 2022: Metformin and reduced vitamin B12 levels.
  3. de Jager J, Kooy A, Lehert P, et al. Long term treatment with metformin in type 2 diabetes and vitamin B-12 deficiency: randomized controlled trial. BMJ. 2010;340:c2181.
  4. Aroda VR, Edelstein SL, Goldberg RB, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2016;39(4):e for details.
  5. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and H2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442.
  6. Cochrane Review. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. 2018 update.
  7. Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses metformin-induced vitamin B12 malabsorption. Diabetes Care. 2000.

Related Topics

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.